Brazilian lung cancer study reveals how patients are really treated

NCT ID NCT07109154

Recruiting now Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Nov 17, 2025 · Last updated May 25, 2026 · Updated 26 times

Summary

This study observes 200 adults with advanced non-small cell lung cancer starting their first treatment in Brazil between 2025 and 2026. Researchers will review medical records and survey doctors to understand which therapies are chosen and if they follow national guidelines. The goal is to learn about patient characteristics and improve future care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
ACTIVE_NOT_RECRUITING

Recife, Brazil
Research Site
RECRUITING

Rio de Janeiro, Brazil
Research Site
NOT_YET_RECRUITING

Rio de Janeiro, Brazil
Research Site
RECRUITING

Salvador, Brazil
Research Site
NOT_YET_RECRUITING

Salvador, Brazil
Research Site
ACTIVE_NOT_RECRUITING

São Paulo, Brazil
Research Site
NOT_YET_RECRUITING

São Paulo, Brazil

Conditions

Explore the condition pages connected to this study.

LUNG NEOPLASMS